AzTrials
AzTrials

SciaticaDSNCT07050108

Neurodynamic Moblization Versus Mulligan on Pain and Functional Abilities in Patients With Chronic Discogenic Sciatica

A study testing neurodynamic mobilization, mulligan therapy and selected physical therapy program in people with Sciatica and Discogenic Pain, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the present study to compare between the effect of neurodynamic moblizaton and Mulligan SNAG's moblization on patients with chronic unilateral discogenic sciatica. Read more about this study

Who is it for?
Ages 35 to 50 years
Conditions the study is for
Sciatica, Discogenic Pain
What is being tested?
neurodynamic mobilization, mulligan therapy and selected physical therapy program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteEgypt
Study dates
10 Aug 2025to 28 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • All the patients diagnosed as lumbar radiculopathy (L5-S1) for at least six months. Diagnosis was confirmed by physical, neurological examination (motor assessment, sensory assessment, reflexes) and radiological assessment (CT or MRI).
  • All patients has second grade of disc bulge which will detect from T2 axial view of MRI according to Fardon and Milette
  • All patients has unilateral radiculopathy and pain in the distribution of scaitic nerve.
  • The age of the patients will range from 35 to 50years . Their body mass index will range between( 22-25)

Who cannot join

  • Bilateral and multilevel disc prolapse or bilateral radtadiating pain
  • acute pain (pain less than three months).
  • Presence of active infection in lumbar spine.
  • Any other spinal deformities.
  • Postoperative cases.
  • Cauda equine lesion.
Show all 10Show fewer
  • Neoplasmic.
  • Spinal stenosis.
  • Mechanical low back pain.
  • Failed back syndrome.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of physical therapy, Cairo University

    Cairo

Other trials in Egypt

About this study

Official title: Effect of Neurodynamic Mobilization Versus Mulligan on Pain and Functional Abilities in Patients With Chronic Discogenic Sciatica

The purpose of the present study to compare between the effect of neurodynamic moblizaton and Mulligan SNAG's moblization on patients with chronic unilateral discogenic sciatica.

Read the detailed description

Sciatica is a common problem in patients suffer from lumbar disc prolapse with an incidence of five cases per 1000 adults in developed countries . Sciatica causes significant disability. When applying neurodynamics, tension occurs in the nervous system, and pressure within the nerve increases due to the decrease of the cross-sectional area, and the axonal transport system lengthens the sciatic nerve after shortening because of the influence of the surrounding related structures and hamstring flexibility . After extention of the nerve and muscle, muscle performance is improved because of increases in the number of muscle fiber segments and cross-sectional area of muscle fibers.The majority of the research concerned with SNAG techniques has concentrated on the study of peripheral joints and the cervical region. Few studies have been concerned with the effects of SNAG on the lumbar spine. The rest of the available research was in the form of case reports or case series. Only 5 trials have investigated different effects of the SNAG technique when applied to the lumbar region. This study will improve the conservative treatment for sciatica and will decrease the cost of treatment and disability of the patient.

Being tested
neurodynamic mobilization, mulligan therapy, selected physical therapy program
Keywords
Neurodynamic Moblization, mulligan therapy, sciatica
Medical subject headings
Sciatica

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • neurodynamic mobilizationOther

    the patients will receive neurodynamic mobilization in the form of opening technique which include; static opening and dynamic opening. also, sliding and tensioning technique+ selected physical therapy program

  • mulligan therapyOther

    sustained natural apophyseal glide SNAGs are mobilisation techniques and are used as part of the Mulligan Concept+ selected physical therapy program The patient position is stitting on the edage of the plenth non weight bearing position. The therapist will stand behind the patient, the therapist will apply SNAG for 3 repetitions during the initial screening session,the patient will be asked to lean forwared while applying the technique .the therapist apply onle from fove to seven repetitions.patients who experienced no worsening or showed improvement of pain and ROM were considered good indication for the effectivness of treatment .

  • selected physical therapy programOther

    The program of therapeutic exercises consisted of upper and lower back exercises. Each exercise will repeat from ten to thirty times, three repetitions in three sets with rest one to two minutes between the sets. The repetition of each exercise vary according to the physical ability of each patient.

    Lower back strengthening exercises: From prone lying position, the patient will asked to raise one lower limb then the other then both lower limbs+ TENS and US

Study groups in NCT07050108
Study groupRoleWhat they receive
neurodynamic mobilizationExperimentaltwenty two patients will receive neurodynamic mobilization and selected physical therapy program three times a week for four weeks
Receives: Other: neurodynamic mobilization; Other: selected physical therapy program
Mulligan therapyExperimentaltwenty two patients will receive mulligan therapy and selected physical therapy program three times a week for four weeks
Receives: Other: mulligan therapy; Other: selected physical therapy program
selected physical therapy programActive comparatortwenty two patients will selected physical therapy program three times a week for four weeks
Receives: Other: selected physical therapy program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pressure pain threshold

    ALgometer offer real-time visual \& auditory feedback to control \& monitor applied pressure rates to measure pressure pain threshold.

    Measured: up to four weeks

  2. pain intensity

    Sciatica Bothersomeness Index will be used to assess pain intensity. An index based on patients reporting of symptoms which reflects the troubled patient is going through with his sciatica symptoms. Items from the Sciatica Bothersomeness Index (0 = none to 6 = extremely) were used to establish values for paresthesia, weakness and leg pain.

    Measured: up to four weeks

Secondary outcomes (2)
  1. Range of motion assessment of straight leg raise

    A unilevel inclinometer will be used to assess the straight leg raise (SLR) test. From supine lying position on a flat plinth towards the side of the examiner, with the neck in a neutral position. The examiner places one hand under the Achilles tendon and the other hand held the inclinometer. The inclinometer must be held in a vertical position during the SLR test by the examiner's hand between the index and the middle fingers and center of inclinometer will be positioned on the lower third of tibia. The leg will be lifted perpendicular to the point at which the patient expressed the perception of pain and the therapist will prevente any knee flexion. The angle of hip flexion during SLR will be measured

    Measured: up to four weeks

  2. disability

    Roland-Morris Disability Questionnaire will be used to assess disability.The RMQ is a 24-item patient-reported outcome measure that inquires about pain-related disability resulting from LBP and discogenic sciatica .total RMQ score ranging from 0 to 24; higher scores represent higher levels of pain-related disability

    Measured: up to four weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2025
  2. Study start10 Aug 2025
  3. Primary completion10 Jan 2026
  4. Study completion28 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
neurodynamic ans mulligan
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07050108
Sponsor's protocol ID
P.T.REC/012/004903
Acronym
DS
Status last verified
Mar 2026
First submitted
25 Jun 2025
Last updated
5 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing neurodynamic mobilization, mulligan therapy and selected physical therapy program in people with Sciatica and Discogenic Pain, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pressure pain threshold (time frame: up to four weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in